Making it easier to calibrate the correct dose of medical marijuana may prompt more physicians to prescribe it as an alternative to a painkiller such as opioids, according to one Canadian company.
Tag Archives: Inhaler
On Nov. 28, 2016, Teva Pharmaceuticals (NYSE:TEVA) announced that it had entered into an agreement with Syqe Medical to market and distribute Syqe’s medical cannabis inhaler in Israel for pain management, signifying the first time a medical cannabis product will be marketed by an international pharmaceutical company.
IRVINE, Calif., Aug. 11, 2016 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis based medicines, is happy to announce their first batch order for the previously announced cannabinoid based inhalation medicine for Asthma/COPD has been placed.
The use of medical marijuana has been debated for decades. The proponents of legalizing it believe that it is an efficient method that can be used to reduce the suffering of millions of people worldwide, while also minimizing the use of more dangerous and addictive narcotic pain killers such as Oxycontin, Percocet, Demerol and Vicodin.